Anti-viral Effects of Pavetta indica Methanolic Extract and Acyclovir on Behavioral and Biochemical Parameters in Streptozotocin-induced Alzheimer's Disease in Rats
- PMID: 38685761
- DOI: 10.2174/0118715303273145240110100341
Anti-viral Effects of Pavetta indica Methanolic Extract and Acyclovir on Behavioral and Biochemical Parameters in Streptozotocin-induced Alzheimer's Disease in Rats
Abstract
Background: Alzheimer's disease is a neurological dysfunction of the brain caused by neurodegeneration and oxidative stress. Some viruses, such as herpes viruses, HSV-1, and HSV-2, are causative agents of Alzheimer's disease and result in β-amyloid peptide and tau protein accumulation in the brain. Some antiviral drugs, such as valacyclovir, acyclovir, and foscarnet, reduce amyloid-beta and P-tau. Pavetta indica leaves are also reported for their antiviral properties. The current study aimed to find out the significance of using Pavetta indica methanolic extract and acyclovir against Alzheimer's disease induced by streptozotocin.
Methods: Wistar rats received acyclovir and Pavetta indica methanolic extract orally at different dose ranges (50, 150, 450 mg/kg) and (125, 250, 500 mg/kg), respectively. The standard therapy, Rivastigmine (2 mg/kg), was given orally.
Results: Intracerebroventricular-streptozotocin produced significant alternations in behavioral assessments, including locomotor activity test, Morris water maze test, and elevated plus maze test. Moreover, intracerebroventricular-streptozotocin ameliorated the antioxidant defense activity by decreasing levels of catalase, superoxide dismutase, and reduced glutathione while enhancing the oxidative stress markers, including malondialdehyde, and total nitrite levels. Finally, the main findings showed that intracerebroventricular-streptozotocin significantly increased the inflammatory marker, tumor necrosis factor-α, and disturbed neurotransmitter mediators, including levels of acetylcholinesterase, glutamate, and γ-amino butyric acid.
Conclusion: In a dose-dependent manner, acyclovir and Pavetta indica methanolic extract treatments abrogated the streptozotocin-induced behavioral and neurological abnormalities in rats. The potential therapeutic effects of PIME and acyclovir administration in intracerebroventricular-streptozotocin-treated rats may be attributed to its potential antiviral, antioxidant, and anti-inflammatory effects. The current study suggests that Pavetta indica methanolic extract and acyclovir are promising therapeutic targets against Alzheimer's disease.
Keywords: Alzheimer's disease; Morris water maze; Pavetta indica; acetylcholinesterase; acyclovir; gamma-aminobutyric acid..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Aegle marmelos leaf extract ameliorates the cognitive impairment and oxidative stress induced by intracerebroventricular streptozotocin in male rats.Life Sci. 2019 Mar 15;221:196-203. doi: 10.1016/j.lfs.2019.02.032. Epub 2019 Feb 14. Life Sci. 2019. PMID: 30771313
-
Methanolic extract of Piper nigrum fruits improves memory impairment by decreasing brain oxidative stress in amyloid beta(1-42) rat model of Alzheimer's disease.Cell Mol Neurobiol. 2014 Apr;34(3):437-49. doi: 10.1007/s10571-014-0028-y. Epub 2014 Jan 19. Cell Mol Neurobiol. 2014. PMID: 24442916 Free PMC article.
-
Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer's dementia in rats: Erythropoietin versus curcumin.Eur J Pharmacol. 2016 Jan 5;770:52-60. doi: 10.1016/j.ejphar.2015.11.046. Epub 2015 Dec 2. Eur J Pharmacol. 2016. PMID: 26638997
-
Bergenia ciliata ameliorates streptozotocin-induced spatial memory deficits through dual cholinesterase inhibition and attenuation of oxidative stress in rats.Biomed Pharmacother. 2018 Jun;102:966-980. doi: 10.1016/j.biopha.2018.03.115. Epub 2018 Apr 5. Biomed Pharmacother. 2018. PMID: 29710552
-
Ozone: complicated effects in central nervous system diseases.Med Gas Res. 2025 Mar 1;15(1):44-57. doi: 10.4103/mgr.MEDGASRES-D-24-00005. Epub 2024 Oct 2. Med Gas Res. 2025. PMID: 39436168 Free PMC article. Review.
References
-
- Gustavsson A.; Norton N.; Fast T.; Frölich L.; Georges J.; Holzapfel D.; Kirabali T.; Krolak-Salmon P.; Rossini P.M.; Ferretti M.T.; Lanman L.; Chadha A.S.; van der Flier W.M.; Global estimates on the number of persons across the Alzheimer’s disease continuum. Alzheimers Dement 2023,19(2),658-670 - DOI - PubMed
-
- Fulop T.; Tripathi S.; Rodrigues S.; Desroches M.; Bunt T.; Eiser A.; Bernier F.; Beauregard P.B.; Barron A.E.; Khalil A.; Plotka A.; Hirokawa K.; Larbi A.; Bocti C.; Laurent B.; Frost E.H.; Witkowski J.M.; Targeting impaired antimicrobial immunity in the brain for the treatment of alzheimer’s disease. Neuropsychiatr Dis Treat 2021,17,1311-1339 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical